ChristopherWillettMDFASTRO
Radiation Oncology • Durham, NCProfessor of Radiation Oncology, Duke University
Dr. Willett is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4101 N Roxboro St
Durham, NC 27704Phone+1 919-684-8111Fax+1 919-668-7345
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Radiation Oncology, 1985 - 1986- Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Radiation Oncology, 1982 - 1984
Vanderbilt University Medical CenterInternship, Transitional Year, 1981 - 1982
Tufts University School of MedicineClass of 1981
Certifications & Licensure
VA State Medical License 2004 - 2026
NC State Medical License 2004 - 2025
SC State Medical License 2020 - 2023
MA State Medical License 1986 - 2007- American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- Gold Medal ASTRO, 2016
- America's Top Doctors Castle Connolly, 2002-2014
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- Join now to see all
Clinical Trials
- Bevacizumab, Fluorouracil, and External-Beam Radiation Therapy in Treating Patients With Stage II or Stage III Rectal Cancer Start of enrollment: 2002 Aug 01
Publications & Presentations
PubMed
- 670 citationsGastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.Jaffer A Ajani, Thomas A D'Amico, David J Bentrem, Joseph Chao, David Cooke
Journal of the National Comprehensive Cancer Network. 2022-02-01 - 265 citationsRectal Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.Al B Benson, Alan P Venook, Mahmoud M Al-Hawary, Nilofer Azad, Yi-Jen Chen
Journal of the National Comprehensive Cancer Network. 2022-10-01 - 187 citationsPrognostic factors in stage T3N0 rectal cancer: do all patients require postoperative pelvic irradiation and chemotherapy?Christopher G. Willett, Kamran Badizadegan, Marek Ancukiewicz, Paul C. Shellito
Diseases of the Colon and Rectum. 1999-02-01
Lectures
- 2013 Gastrointestinal Cancers Symposium (AGA/ASCO/ASTRO/SSO)American Society of Clinical Oncology(ASCO), San Francisco, California - 1/24/2013
Other
- Clinical features, staging, and treatment of anal cancerWillett CG, Ryan DP
http://www.uptodate.com/contents/clinical-features-staging-and-treatment-of-anal-cancer
UpToDate, Wolters Kluwer Health - 2013-03-26 - Classification and epidemiology of anal cancerWillett CG, Ryan DP
http://www.uptodate.com/contents/classification-and-epidemiology-of-anal-cancer
UpToDate, Wolters Kluwer Health - 2012-12-20 - Adjuvant therapy for resected rectal cancerWillett CG, Ryan DP
http://www.uptodate.com/contents/adjuvant-therapy-for-resected-rectal-cancer
UpToDate, Wolters Kluwer Health - 2013-04-09 - Join now to see all
Press Mentions
Shop TalkSeptember 20th, 2016
Development of New Blood Vessels Not Essential to Growth of Lymph Node MetastasesJuly 17th, 2015
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
